Stallergenes Greer logo
Stallergenes Greer Chooses Flex Databases eTMF to Enhance Inspection Readiness and Oversight Efforts

Stallergenes Greer, a global healthcare company specializing in allergy diagnosis and treatment through allergy immunotherapy (AIT) products, has chosen Flex Databases as its eTMF vendor. The answers were provided by Virginie Lobrégat-Duriez, Director of Clinical Operations, and Dominique Jouny, Senior Clinical Project Manager. Q1. What did Stallergenes Greer have to start looking for an eTMF […]

Learn more
AI eTMF Webinar
Webinar with Deloitte | AI in eTMF – Auto-Classification and Metadata: Efficiency and Compliance

Join us for an exclusive insightful webinar as we explore Artificial Intelligence (AI) within the Electronic Trial Master File (eTMF) system. Explore how AI can transform document management, simplify processes, and maintain compliance with regulatory standards. What to Expect? Have burning questions about AI implementation in eTMF? This webinar offers the perfect opportunity to have […]

Learn more
AI validation for life sciences – a unique challenge of dynamic nature

What aspects need validation to ensure confidence in AI-driven processes, and is it possible to achieve 100% certainty?

Learn more
how we implenented eTMF
How we implemented eTMF & developed SOPs in 3 weeks for iRenix

And here’s the twist – while iRenix was laser-focused on their operations and study start-up processes, we rolled up our sleeves to deliver a full-on, turn-key eTMF setup from scratch.

Learn more
Deloitte and Flex Databases
Deloitte and Flex Databases forge strategic alliance to drive digitalisation in Life Sciences across Europe

This collaboration is set to transform the Life Sciences sector by leveraging Deloitte’s expertise in process management, validation, onboarding, and consulting, alongside Flex Databases’ state-of-the-art electronic systems.

Learn more
TMF Quality Review 2.0
TMF Quality Review 2.0 

Periodic TMF reviews automatically documented. Quality and completeness under control!

Learn more

Join our newsletter

Want to get the latest news on clinical trials?